NeuroDerm CEO to Present at Upcoming Investor Conferences

REHOVOT, Israel, Feb. 24, 2015 (GLOBE NEWSWIRE) — NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced that CEO Oded S. Lieberman, PhD will present at the following investor conferences in March:
• Cowen and Company 35th Annual Health Care Conference taking place in Boston, Massachusetts from March 2 – 4, 2015. Dr. Lieberman’s presentation will take place on Monday, March 2, at 2:50pm ET.
• 27th Annual ROTH Conference taking place in Laguna Niguel, California from March 8 – 11, 2015. Dr. Lieberman’s presentation will take place on Monday, March 9 at 3:00pm PT, 6:00pm ET.

To access the live webcasts of these presentations, please visit Replays will be available for one month following each presentation.

About NeuroDerm

NeuroDerm is a clinical-stage pharmaceutical company developing central nervous system (CNS) product candidates that are designed to overcome major deficiencies of current treatments and achieve enhanced clinical efficacy through continuous, controlled administration. NeuroDerm is headquartered in the Rabin Science Park, Rehovot, Israel.

NeuroDerm Contact:
Oded S. Lieberman, PhD MBA, CEO
[email protected]
Tel.: +972-8-946 2729
Cell: +1-617-517-6077

U.S. Investor Contact:
David Carey
Lazar Partners Ltd.
[email protected]

U.S. Media Contact:
Hollister Hovey
Lazar Partners Ltd.
[email protected]
NeuroDerm Ltd.